Nyxoah S.A. (NYXH)
Automate Your Wheel Strategy on NYXH
With Tiblio's Option Bot, you can configure your own wheel strategy including NYXH - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol NYXH
- Rev/Share 0.1221
- Book/Share 3.0577
- PB 2.201
- Debt/Equity 0.2
- CurrentRatio 4.5559
- ROIC -0.448
- MktCap 251901397.3287
- FreeCF/Share -1.4285
- PFCF -4.761
- PE -4.2081
- Debt/Assets 0.143
- DivYield 0
- ROE -0.5568
- Rating C-
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 2
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Nyxoah S.A. Being Investigated on Behalf of Nyxoah S.A.
Published: March 31, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / March 31, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Nyxoah S.A. ("Nyxoah S.A.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH
Published: March 31, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , March 31, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. ("Nyxoah" or the "Company") (NASDAQ: NYXH).
Read More
Nyxoah S.A. Being Investigated on Behalf of Nyxoah S.A.
Published: March 27, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / March 27, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Nyxoah S.A. ("Nyxoah S.A.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH
Published: March 27, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / March 27, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. ("Nyxoah" or the "Company") (NASDAQ:NYXH).
Read More
FDA Issues Nyxoah an Approvable Letter for its Genio® System
Published: March 26, 2025 by: GlobeNewsWire
Sentiment: Neutral
INSIDE INFORMATION REGULATED INFORMATION FDA Issues Nyxoah an Approvable Letter for its Genio® System Mont-Saint-Guibert, Belgium – March 26, 2025, 8:00am CET / 3:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the U.S. Food and Drug Administration (FDA) has issued an Approvable Letter regarding the Company's Pre-Market Approval (PMA) application for the Genio® system. The Approvable Letter means that Nyxoah's application for marketing the device in the United States substantially meets the requirements of the Federal Food, Drug and Cosmetic Act …
Read More
Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
Published: March 03, 2025 by: GlobeNewsWire
Sentiment: Neutral
Nyxoah to Participate in the Oppenheimer 35 th Annual Healthcare MedTech & Services Conference
Read More
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East
Published: February 19, 2025 by: GlobeNewsWire
Sentiment: Neutral
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East First patient implanted with Genio at Saudi German Hospital in Dubai, United Arab Emirates
Read More
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East
Published: February 19, 2025 by: GlobeNewsWire
Sentiment: Neutral
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East First patient implanted with Genio at Saudi German Hospital in Dubai, United Arab Emirates
Read More
About Nyxoah S.A. (NYXH)
- IPO Date 2021-04-28
- Website https://www.nyxoah.com
- Industry Medical - Instruments & Supplies
- CEO Mr. Olivier Taelman
- Employees 183